Open AccessMP16-01 EFFICACY OF INTRAVESICAL NADOFARAGENE FIRADENOVEC FOR PATIENTS WITH CARCINOMA IN SITU (CIS), BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC): LONGER-TERM FOLLOW-UP FROM THE PHASE III TRIAL
Author(s) -
Anne Schuckman,
Yair Lotan,
Stephen A. Boorjian,
Katherine E. Cilwa,
Colin P.N. Dinney
Publication year - 2021
Publication title -
the journal of urology/the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1097/ju.0000000000002001.01
Subject(s) - medicine , carcinoma in situ , bladder cancer , urology , in situ , cancer , oncology , physics , meteorology